ADELINA ALEJOS RIVERA: Open Payments
NPI 1861239014 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 42 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $1,380
Food & beverage: $1,380
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $311 |
| Otsuka America Pharmaceutical, Inc. | 10 | $301 |
| E.R. Squibb & Sons, L.L.C. | 4 | $283 |
| Janssen Pharmaceuticals, Inc | 6 | $238 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| Alkermes, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, COBENFY, REXULTI, INVEGA SUSTENNA, INGREZZA, ARISTADA, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
